The Study on Effects of CYP3A and P-glycoprotein Inhibitor Itraconazole and CYP Enzyme Inducer Rifampin of HMPL-453 Tartrate Tablets

NCT07697157 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Health, Subjective

Interventions

DRUG: HMPL-453 with Itraconazole
DRUG: HMPL-453 with Rifampin

Sponsor

Hutchmed